Cite
IMMUNE CHECKPOINT INHIBITOR THERAPY-RELATED PNEUMONITIS: EFFECT ON PULMONARY FUNCTION TESTING
MLA
Riestra Guiance, Irene, et al. “Immune Checkpoint Inhibitor Therapy-Related Pneumonitis: Effect on Pulmonary Function Testing.” Chest, vol. 164, no. 4, Number 4 Supplement 1, Oct. 2023, p. A3016. EBSCOhost, https://doi.org/10.1016/j.chest.2023.07.1978.
APA
Riestra Guiance, I., Hazim, A., Ruan, G., Mcconn, K., Mcglothlin, J., Haemmerle, R., Leventakos, K., & Egan, A. (2023). Immune Checkpoint Inhibitor Therapy-Related Pneumonitis: Effect on Pulmonary Function Testing. Chest, 164(4, Number 4 Supplement 1), A3016. https://doi.org/10.1016/j.chest.2023.07.1978
Chicago
Riestra Guiance, Irene, Antonious Hazim, Gordon Ruan, Keith Mcconn, John Mcglothlin, Robert Haemmerle, Konstantinos Leventakos, and Ashley Egan. 2023. “Immune Checkpoint Inhibitor Therapy-Related Pneumonitis: Effect on Pulmonary Function Testing.” Chest 164 (4, Number 4 Supplement 1): A3016. doi:10.1016/j.chest.2023.07.1978.